
AstraZeneca PLC
LSE:AZN

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9 667
13 276
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
AZN
stock under the Base Case scenario is
14 568.64
GBX.
Compared to the current market price of 10 420 GBX,
AstraZeneca PLC
is
Undervalued by 28%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
AstraZeneca PLC
Historical valuation for AZN cannot be conducted due to limitations such as insufficient data or other constraints.
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:


Revenue & Expenses Breakdown
AstraZeneca PLC
Balance Sheet Decomposition
AstraZeneca PLC
Current Assets | 26.1B |
Cash & Short-Term Investments | 5.4B |
Receivables | 14.8B |
Other Current Assets | 5.9B |
Non-Current Assets | 80.1B |
Long-Term Investments | 1.9B |
PP&E | 12.3B |
Intangibles | 58.7B |
Other Non-Current Assets | 7.2B |
Current Liabilities | 29.1B |
Accounts Payable | 22.5B |
Short-Term Debt | 1.4B |
Other Current Liabilities | 5.2B |
Non-Current Liabilities | 36.1B |
Long-Term Debt | 27.9B |
Other Non-Current Liabilities | 8.2B |
Free Cash Flow Analysis
AstraZeneca PLC
USD | |
Free Cash Flow | USD |
Earnings Waterfall
AstraZeneca PLC
Revenue
|
55B
USD
|
Cost of Revenue
|
-9.7B
USD
|
Gross Profit
|
45.3B
USD
|
Operating Expenses
|
-32.1B
USD
|
Operating Income
|
13.2B
USD
|
Other Expenses
|
-5.5B
USD
|
Net Income
|
7.8B
USD
|
AZN Profitability Score
Profitability Due Diligence
AstraZeneca PLC's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Score
AstraZeneca PLC's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
AZN Solvency Score
Solvency Due Diligence
AstraZeneca PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Score
AstraZeneca PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AZN Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for
AZN
is 13 530.29 GBX
with a low forecast of 6 864.74 GBX and a high forecast of 18 270 GBX.
Dividends
Current shareholder yield for AZN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AZN
stock under the Base Case scenario is
14 568.64
GBX.
Compared to the current market price of 10 420 GBX,
AstraZeneca PLC
is
Undervalued by 28%.